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Abstract
Background: The Integrated Infectious Disease Capacity-Building Evaluation (IDCAP) was designed to test the
effects of two interventions, Integrated Management of Infectious Disease (IMID) training and on-site support (OSS),
on clinical practice of mid-level practitioners. This article reports the effects of these interventions on clinical
practice in management of common childhood illnesses.
Methods: Two trainees from each of 36 health facilities participated in the IMID training. IMID was a three-week
core course, two one-week boost courses, and distance learning over nine months. Eighteen of the 36 health
facilities were then randomly assigned to arm A, and participated in OSS, while the other 18 health facilities
assigned to arm B did not. Clinical faculty assessed trainee practice on clinical practice of six sets of tasks: patient
history, physical examination, laboratory tests, diagnosis, treatment, and patient/caregiver education. The effects of
IMID were measured by the post/pre adjusted relative risk (aRR) of appropriate practice in arm B. The incremental
effects of OSS were measured by the adjusted ratio of relative risks (aRRR) in arm A compared to arm B. All
hypotheses were tested at a 5 % level of significance.
Results: Patient samples were comparable across arms at baseline and endline. The majority of children were
aged under five years; 84 % at baseline and 97 % at endline. The effects of IMID on patient history (aRR = 1.12;
95 % CI = 1.04-1.21) and physical examination (aRR = 1.40; 95 % CI = 1.16-1.68) tasks were statistically significant.
OSS was associated with incremental improvement in patient history (aRRR = 1.18; 95 % CI = 1.06-1.31), and
physical examination (aRRR = 1.27; 95 % CI = 1.02-1.59) tasks. Improvements in laboratory testing, diagnosis,
treatment, and patient/caregiver education were not statistically significant.
Conclusion: IMID training was associated with improved patient history taking and physical examination, and
OSS further improved these clinical practices. On-site training and continuous quality improvement activities
support transfer of learning to practice among mid-level practitioners.
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Introduction
Globally, 6.6 million children aged under five years died
in 2012 [1]. Their leading causes of death in sub Saharan
Africa included pneumonia, diarrhea, malaria and
health problems during the first month of life [2]. Over
two-thirds of these early childhood deaths could be pre-
vented or treated with access to simple and affordable
interventions [2]. Although the mortality rate among
children aged under five years in Uganda declined from
178 per 1,000 live births in 1990 to 90 per 1,000 live
births in 2011, it remains high compared to the average
rate of 51 per 1,000 live births globally [3, 4]. Cross-
country comparisons show that health outcomes im-
proved and coverage of cost-effective interventions in-
creased with more health workers. Mortality among
infants and children under five years of age were in-
versely related to the total number of doctors, nurses,
and midwives per 10,000 population, and vaccination
coverage was positively related to it [5, 6].
The World Health Organization (WHO) recommends
task shifting as one method of strengthening and expanding
the health workforce to rapidly increase access to health
services [7, 8]. Task shifting is a process of delegation of
tasks, where appropriate, to less specialized health workers
and is a strategy to address health worker shortage and im-
prove health care coverage [7, 9]. In countries with an in-
adequate healthcare work force, some clinical
responsibilities have been transferred from doctors to
mid-level healthcare providers such as clinical officers
and registered nurses [8, 10, 11]. Policy discussions
about task shifting or sharing have moved from
whether or not clinical officers and registered nurses
can effectively perform clinical tasks traditionally re-
served for doctors to what are the most effective
methods for improving their capacity to perform those
tasks [12, 13].
Evidence from the Integrated Management of Childhood
Illness (IMCI) Multi-Country Evaluation showed that train-
ing improved the quality of care, but there was room for
further improvement [14–18]. Among health workers with
IMCI training, the quality of care was better with at least
one supervision visit every six months in Uganda [14), and
with study supports including supervision in Benin (19].
Horwood et al. (2009) recommended further research on
the role of supervision to maintain IMCI skills and on dif-
ferent models of supervision [20]. The Joint Uganda Mal-
aria Training Program (JUMP) combined classroom
sessions, practice and supervision visits, and was effective
at improving case management of fever among children
[21]. Several of these facilities achieved high levels of per-
formance after four years of ongoing site visits with data
surveillance and feedback [22].
The objectives of the Integrated Infectious Disease
Capacity Building Evaluation (IDCAP) were to design
two integrated training interventions for mid-level prac-
titioners (MLP), evaluate their effectiveness, and esti-
mate their cost-effectiveness at 36 facilities in Uganda.
The two interventions were an Integrated Management
of Infectious Diseases (IMID) training program, and on-
site support (OSS). The effects of the interventions on
the clinical competence and clinical practice of individ-
ual MLP, 23 facility performance indicators, and mortal-
ity among children under five years of age were tested.
Clinical competence measured by vignettes, which are
sometimes referred to as case scenarios, increased sig-
nificantly after the 3-week core IMID course and per-
sisted for 24 weeks; no incremental effect of OSS was
observed [23]. Similarly IMID was associated with statis-
tically significant improvements in two facility perform-
ance indicators, and the combination of IMID and OSS
were associated with statistically significant improve-
ments in five [24, 25]. Despite large incremental effects
of OSS on 10 indicators, none were statistically signifi-
cant. The results for clinical practice in management of
common childhood illnesses are reported below.
Methods
Trial design
The evaluation of clinical practice was conducted be-
tween January 2010 and February 2011, and had a mixed
design with pre/post and cluster-randomized trial com-
ponents.. Thirty-six eligible health facilities were selected
from all major regions of Uganda [26] and randomized
as clusters, because many of the facility performance in-
dicators depended on a team of clinicians, laboratory
professionals and other staff rather than individuals.
Each facility selected two MLP, who were clinical offi-
cers, registered nurses, or registered midwives to partici-
pate in the IMID training program. The clinical officers
had a secondary school education, three years of pre-
service training, and two years of internship. The regis-
tered nurses and registered midwives had a secondary
school education, and three years of pre-service training.
Eighteen health facilities were then randomly assigned to
receive OSS (arm A) in 2010 while the other 18 facilities
received it in 2011 and served as a control for OSS dur-
ing the trial (arm B). The full protocol is available as a
supplementary file for Mbonye et al. [24] and Weaver
et al. [25]. The CONSORT Checklist for the trial is in
Additional file 1.
Facilities
The health facilities comprised of 31 Health Centers IV
and five general hospitals. These facilities served a sub-
district population of 1.39 million or 4.5 % of the 30.66
million projected population in 2009 [24, 25, 27]. Two
key inclusion criteria were: 1) facilities were accredited
to provide anti-retroviral therapy (ART) to patients with
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HIV, and 2) facilities with a functional laboratory defined
as performing six tests: malaria blood smear, human im-
munodeficiency virus (HIV) rapid test, tuberculosis (TB)
sputum smear, urinalysis, stool analysis, and haemoglo-
bin estimation. For more details on inclusion criteria for
health facilities see Miceli et al. [28] and Naikoba et al. [26].
Trainees
The MLP trainees were clinical officers (CO) and regis-
tered nurses (RN) who managed patients in the out-
patient clinics, devoted at least 80 % of their time to
patient care, and were available to participate in the
evaluation for 21 months [26, 28]. The district agreed
not to transfer the trainee, and the trainee did not fore-
see a need to change his/her assignment. If a facility did
not have two COs who met these criteria, an RN was se-
lected and if an RN was not available, one trainee could
be a registered midwife. Two desirable criteria for
trainees were: 1) leadership role such as in-charge of
ward or clinic, or focal person for malaria, TB, HIV, pre-
vention of mother-child transmission of HIV (PMTCT),
and 2) previous training and experience in counseling or
IMCI or Integrated Management of Adult Illness
(IMAI). For the clinical assessments, trainees were ex-
cluded from the analysis if they were observed managing
only patients 14 years of more of age.
Patient selection
Patients were a convenience sample who reported to the
clinic on the day of the assessment was conducted by
the clinical faculty. Patients under five years of age were
preferred, but older children were selected when there
were no younger patients at the facility on the day of the
assessment.
Interventions
IMID training program was a three-week core course,
followed over a nine-month period by distance learning
and two one-week boost courses at 12 and 24 weeks
after the initial training. The aim of IMID was to im-
prove diagnosis and management of malaria, TB and
HIV/AIDS and related infectious diseases in children,
pregnant women, and other adults. The course content
was guided by learning need assessments, such as Lutalo
et al. [29]. It built on content from WHO’s IMAI [30]
and IMCI [31] courses; IDI’s Comprehensive HIV Care
including ART [32] and Joint Uganda Malaria Training
Program (JUMP) [21] courses, and updated national and
WHO guidelines on treatment of malaria, TB and HIV/
AIDS. It also included sessions on continuous quality
improvement [33], with adaptations for low and middle
income countries. Detailed description of the develop-
ment and content of the IMID course is in Miceli et al.
[28]. Between courses, trainees continued the learning
process by reviewing and documenting 10 case write-
ups from a menu linked to material covered in the core
course. Technical experts based at IDI provided distance
support on request for all trainees. Trainees in arm A
attended the IMID core course in March and April 2010
while those in arm B attended in May and June 2010.
The OSS intervention combined educational outreach
and continuous quality improvement (CQI). A mobile fac-
ulty team visited each facility in arm A for two days, once a
month for a period of nine months. Each mobile faculty
team was comprised of a medical officer with CQI expert-
ise, a clinical officer, a nursing officer, and a laboratory tech-
nologist. OSS sought to improve individual practice
through clinical mentoring. At each of the facilities in arm
A, eight clinicians spending 80 % of their time on patient
care were selected for one-to-one mentoring by two clinical
faculty (medical officer and clinical officer) while the la-
boratory staff were mentored by the laboratory technolo-
gist. OSS also sought to build and foster team work,
improve facility performance, and support the use of data
to monitor facility performance through multidisciplinary
team (MDT) training, cadre-specific clinical breakout ses-
sions, and CQI activities. All clinical staff were invited to
participate in the MDT training sessions and their respect-
ive cadre specific break-out sessions. The break-out session
for clinicians may have also contributed to improving clin-
ical practice. IMID trainees in arm A were required to at-
tend seven of nine OSS sessions to receive a certificate.
During each OSS visit, the MDTand cadre-specific sessions
were focused on a selected topic from a predefined list of
priority areas. A new topic was addressed each visit, and
follow-up support on topics covered in the previous visits
was also provided. OSS is described in more detail in Miceli
et al. [28] Naikoba et al. [26] and Mbonye et al. [24].
The mobile faculty team acted as role models of how
an MDT could function. The team was centrally based
to avoid contamination of non-intervention facilities,
which could have occurred if the Ministry of Health
(MoH) mentors from the district offices who had other
responsibilities at facilities in both arms were used.
However, for sustainability purposes and to address
health system issues at the district level, the nursing offi-
cer was selected from the district in which the facility
was located. There were five mobile faculty teams, each
responsible for 3–4 study facilities located in the same
or neighboring geographical region.
The medical officers and clinical officers on the mo-
bile faculty team also conducted the clinical assess-
ments. They underwent extensive training prior to the
baseline assessments and delivering the OSS sessions.
They attended IDI’s three-week Comprehensive HIV
Care including ART therapy course, a Trainer of
Trainers course, and a customized two-week course on
mentoring. All members of the mobile faculty team,
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including representatives of the districts, attended a
pilot session of IMID.
Pre-and post-intervention assessment
A “baseline” assessment was conducted between January
and March 2010 prior to any of the interventions and is
referred to as time 0. An “endline” clinical assessment
was conducted from December 2010 to February 2011,
beginning during the ninth OSS visit in arm A, and is
referred to as time 1. At both time 0 and time 1, trainees
were assessed on a single day on at least five patients at
each facility in each time period.
Outcomes
The clinical practice outcomes were six sets of tasks:
1) Appropriate patient history questions asked given
the patient’s presenting symptoms; 2) Physical systems
examined correctly during examination; 3) Appropri-
ate laboratory tests; 4) Correct diagnosis; 5) Correct
treatment (anti-malarials, antibiotics, or other drugs),
and 6) Appropriate education regarding the illness and
medication prescribed provided to the patient or
caregiver.
A pretested standardized assessment tool was used
to record trainees’ clinical practice and anonymous pa-
tient information on these six sets of tasks. The tool
was based on previous IMCI and JUMP evaluation
tools with two important innovations from the work of
Brentlinger et al. [34–37]. The clinical faculty teams: 1)
recorded information on patients as well as trainee
practice so accurate patient information was available,
and 2) interrupted the assessment after the trainee
completed the patient history and physical examin-
ation. This was done to ask additional history ques-
tions and conduct additional physical examination to
complete missing information or correct erroneous in-
formation. Then the assessment of the trainee contin-
ued. History questions included follow-up questions
for patients who presented with fever, ear discharge,
cough, and diarrhea to establish duration and extent of
illness. Consequently the required number of history
questions varied across patients according to their
symptoms. To distinguish patient information ob-
tained by the trainee from that obtained by the faculty
on the same form, trainees’ clinical findings were re-
corded in blue or black ink and the faculty members’
were recorded in red ink.
Construction of outcome variables
History
Trainees were expected to ask patients or caregivers
questions and record correct responses for at least nine
main questions about: danger signs, fever, ear discharge,
cough, diarrhea, immunization status, HIV status of the
child or mother if child’s status was not known, and
other symptoms. Table 1 shows the main questions and
respective follow up questions. The number of appropri-
ate questions depended on the patient’s symptoms and
ranged from eight to 19. The number of appropriate
questions comprised the denominator while the numer-
ator was the number of actual questions the trainee
asked. In the analysis, we modelled the proportion of ap-
propriate questions asked for any given patient.
Physical examination
For each patient assessed, trainees were expected to per-
form a physical examination consisting of eight systems:
a general examination, check for danger signs, and
examination of the respiratory system, abdomen, ears,
skin, basic neurological assessment, and check for any
other clinical signs. These eight systems comprised the
denominator for the physical examination. Growth as-
sessment was not included because of missing data, and
other systems were only included when data were not
missing. The numerator was the number of systems ex-
amined correctly by the trainee, where correct meant
both conducting the examination and identifying the
physical symptom or its absence. In the analysis, we
Table 1 Patient history fields on which trainees were assessed
Main history questions Follow up questions
1 Checked for danger sign
2 Checked for fever If fever is present
2a. Asked about duration
2b. Asked about prior antimalarial use
2c. Asked about history of measles
within last 3 months
2d. Asked about history of ear pain
3 Checked for ear discharge If ear discharge is present
3a. Duration
4 Asked about HIV status
5 Checked for cough If cough is present
5a. Asked about duration
If cough duration >14 days
5b. Asked for history of night sweats
5c. Asked for history of weight loss
5d. Asked for history of contact with
patient with TB
6 Checked for diarrhea If diarrhea is present
6a. Asked about duration
6b. Asked about presence of blood in
stool
7 Checked for immunization
(children < 5y)
8 Checked for other problems
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modelled the proportion of physical systems examined
correctly for any given patient.
Laboratory tests, diagnosis, treatment and patient/caregiver
education
Laboratory tests were measured as a single task meaning
that all appropriate tests were ordered, and diagnosis
measured as a single task meaning that all diagnoses
were correct. Treatment was measured as the proportion
of three types of treatment prescribed correctly: malaria,
antibiotic, and other treatment. Similarly, patient/care-
giver education was measured as the proportion of three
types of information provided correctly: diagnosis, treat-
ment, and instructions for completing treatment. Incor-
rect treatment included both errors of omission (e.g. a
malaria test was not ordered for a patient with fever)
and errors of commission (e.g. an anti-malarial was pre-
scribed for a patient with a negative malaria test result).
Changes after trial commencement
The patient sample and the assessment tool changed.
When some facilities did not have five patients under
five years of age on assessment days, a few trainees were
assessed on children over five years.
The assessment tool was also revised prior to con-
ducting the endline assessment to address problems
with the patient history and physical examination sec-
tions identified at baseline. The patient history ques-
tions about HIV status and immunization were revised.
At baseline, it was unclear whether “yes”, meant that
the child or mother was positive or that the HIV status
was known. Immunization status of the child was simi-
larly unclear as to whether “yes” meant that the
immunization status of the child was up-to-date or
that the child’s immunization card was presented. For
both tasks, a “yes” at baseline was interpreted to mean
that the trainee spoke with the caregiver about the
topic. At endline there were three distinct tasks for
asking about mother’s HIV status, PMTCT, and child’s
HIV status. A “yes” for the child’s status meant that the
child was HIV-positive. For immunization status at
endline, there were two distinct tasks for asking: 1)
Whether or not the child’s immunization status was up
to date, and 2) Whether or not the immunization sta-
tus was verified with an immunization card. Physical
examination questions about the mouth were added to
the form. The endline version of the assessment form
is available for researchers as Additional file 2. Data on
HIV status, immunization and examination of the
mouth were only included in the sensitivity analysis
performed with the endline sample. (See Sensitivity
analysis section below).
Sample size
The sample size calculations for IDCAP were based on
testing the effect of OSS on facility performance where
the unit of analysis was the health facility. The calcula-
tions were reported in Naikoba et al. [26].
Feasibility rather than sample size calculations guided
the number of IMID trainees per facility and number of
patients observed per trainee. The initial proposal was to
train all the MLP at each facility, based on evidence of
the effect of other IDI training programs on clinical
practice [21, 32]. Funding was only available however, to
train two MLP per facility. Similarly, clinical faculty
teams could only spend one day per facility on the clin-
ical assessments of pediatric care, and early experience
at baseline showed that each faculty member could ob-
serve five patients per trainee per day. Given 36 trainees
per arm and five observations per trainee, we planned to
have a sample of 180 observations per arm each time
period. In a simple comparison of proportions at time 1,
a sample size of 180 would detect an increase from 60 %
to 75 % of tasks performed correctly with a power of
0.84 and an increase from 70 % to 85 % of tasks per-
formed correctly with a power of 0.91.
Randomization—sequence generation
Health facilities were assigned to arms by stratified ran-
dom allocation [23, 26]. Facilities were stratified by two
characteristics: 1) prior experience with the Health Care
Improvement program, a national CQI program for HIV
prevention and treatment vs. CQI naïve, and 2) current
or prior participation in the Baylor International
Pediatric AIDS Initiative (BIPAI) on-site intervention, vs.
no BIPAI presence [38]. Facilities were then randomly
assigned to arm A or B (1:1 balance) within those strata.
Randomization of health facilities to arm was imple-
mented using random number generation in Stata 10.1.
We retained a log of the Stata run stream that led to the
randomization and set the “seed” from which the
randomization started so that it could be replicated if
the need arose.
Randomization—allocation concealment
Randomization occurred on February 23, 2010 after the
majority of trainees completed baseline clinical assess-
ments in January and February 2010. Within 2 weeks of
the first session of the IMID course, arm A trainees were
notified of their upcoming course dates and arm assign-
ment. Allocation was not concealed during the interven-
tions and endline assessment.
Clinical faculty member who conducted baseline as-
sessment at a facility may have subsequently been
assigned to provide OSS at that facility. To minimize ob-
server bias in favor of mentees, endline assessments
were conducted by a clinical faculty member who did
Imani et al. BMC Pediatrics  (2015) 15:103 Page 5 of 14
not provide OSS at the facility [39]. However, observer
bias to favor arm A trainees may have existed.
Randomization—implementation
Trainees were assigned to interventions based on the al-
location of their facility to arm.
Blinding
This study was not blinded after randomization in
February 2010.
Data management and statistical methods
Data were coded by a Ugandan medical doctor (PI), en-
tered in Epiinfo3.2® (U.S. Centers for Disease Control
and Prevention, Atlanta GA), cleaned and validated.
Baseline data were entered once and proofread by PI.
Endline data were double entered. All analyses were
performed with Stata 11 (StataCorp, 2009 College Sta-
tion, TX).
Trainee and patient characteristics at baseline were sum-
marized. To test the effect of the intervention on each out-
come, the pre/post (endline vs. baseline) difference in arm
B measured the effect of IMID, and the difference in the
pre/post difference between arm A and B measured the in-
cremental effect of OSS. The patient was the unit of ana-
lysis. For each outcome, patient and time point, we
observed a binomial count of the number of tasks per-
formed correctly, where the total number of appropriate
tasks varied across patients for patient history and physical
examination. We used a generalized linear model, specific-
ally a Poisson family and log link, with main effects for
arm, time period and their interaction to estimate relative
risks (RR) and ratio of relative risks (RRR). Although pa-
tients were observed with random effects for trainee nested
within health facility, preliminary analyses suggested that
the random effect for facility did not affect the results, and
was not included in the primary model reported below. All
regression analyses were clustered on the trainee with ro-
bust variance estimation to adjust for using the Poisson ra-
ther than the binomial family and for over-dispersion. The
results for the interventions were presented as adjusted RR
(aRR) for the effect of IMID, and adjusted RRR (aRRR) for
the incremental effect of OSS, with 95 % confidence inter-
vals (95 % CI). A 5 % level of significance was used with the
caveat that there were multiple comparisons, which in-
creased the chance of a Type I error, i.e. the probability of
erroneously concluding that there was an effect of the
IDCAP interventions.
To address any residual confounding after randomization,
we adjusted for several covariates: trainee profession, the
two strata (CQI experienced and presence of BIPAI at the
facility), and learning during the assessment, which was
measured using a categorical variable taking on values of
one to five for the sequence of the particular patient being
observed for each trainee. We also adjusted for case com-
plexity with two variables: 1) two or more diagnoses, and 2)
patient less than one year of age. We intended to include a
fixed effect for observer, but it was not possible for the pri-
mary model, because of the imbalance of clinical faculty
across facilities and time periods (see Sensitivity analysis
section below). Two alternative variables to adjust for ob-
server were used: 1) the profession of faculty member
(medical officer or clinical officer), and 2) whether or not
the faculty member attended the assessment training ses-
sion for the time period during which the assessment was
conducted.
Several sensitivity analyses were performed with different
subsamples and models. Analyses were repeated with the
subsample of patients with clinical faculty members bal-
anced across facilities and time periods including a fixed ef-
fect for observer instead of the alternate variables described
above. This subsample only included observations of
trainees by the clinical faculty members who conducted as-
sessments at baseline (time 0) and endline (time 1), and
with trainees in both arm A and arm B during each time
period. This is referred to as the balanced sample in the re-
sults below while analysis of all clinical assessments is re-
ferred to as the full sample.
Given the comparable practice across arms A and B at
baseline, analyses were repeated with endline data only
to take advantage of improvements in the assessment
form with experience. Finally, regression diagnostics
were performed to identify outliers and influential obser-
vations and estimates were obtained excluding these
observations.
The primary model was estimated with complete cases
for each set of tasks, meaning that information was re-
ported on each task within a set. For patient history, two
tasks were not included in the full and balanced sample
comparisons, because data were missing for 30 or more
patients: checked for danger signs, and measles within
last three months. (See Additional file 3.) For physical
examination, examination of growth was not included in
the full and balanced sample comparisons for the same
reason. (See Additional file 4.) In addition, “other” sys-
tem was not included in the numerator or the denomin-
ator when data about it were missing. Sensitivity
analyses were performed with two alternative assump-
tions about missing values for the remaining sets of
tasks: 1) all missing values were interpreted as the task
not performed by the trainee, i.e. missing values were
equal to zero, and 2) all missing values were interpreted
as performed by the trainee, i.e. missing values were
equal to one.
Human subjects’ approval
IDCAP was reviewed and approved by the School of
Medicine Research and Ethics Committee of Makerere
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University (Reference number 2009–175) and the
Uganda National Committee on Science and Technology
(Reference number HS-722). The University of Wash-
ington Human Subjects Division determined that the
study did not meet the regulatory definition of research
under 45 CFR 46.102(d).
IMID trainees were asked to provide written informed
consent for secondary analysis of their training program
data for the evaluation. Patients and their caregivers
were introduced to the assessments in the waiting area
on the day of the assessment and asked to provide verbal
informed assent/consent at the beginning of the consult-
ation. The patient data were anonymous, and the verbal
consent process preserved their anonymity.
Recruitment of facilities and trainees
The facilities were recruited between March and September
2009. The registration and consent process for the IMID
training trainees took place between December 2009 and
March 2010.
Results
Facility and trainee flow
Thirty-six health facilities (five hospitals and 31 health
centers) enrolled in this evaluation and participated
throughout. Four of the five hospitals were randomized
to arm B. A total of 72 MLP were selected to participate
in IMID. The MLP comprised of 48 clinical officers, 20
registered nurses and 4 registered midwives. All four
registered midwives were based at facilities randomized
to arm B. Seventy-two percent and 61 % of MLP were
Clinical Officers in arm A and arm B respectively. As
noted above, we controlled for trainee cadre in the ana-
lysis to adjust for potential residual confounding.
A baseline clinical assessment was conducted at 35 fa-
cilities with 69 MLP. Assessments forms for one of the
facilities were unavailable, and one MLP was recruited
after the baseline clinical assessments were completed.
One MLP who only assessed children aged more than
14 years was excluded from the analysis, and one was
excluded for a reason that was not documented.
Randomization was followed by the three-week IMID
core course for all 72 MLP and follow up boost courses
(Fig. 1). Four MLP, one from arm A and three from arm
B were not available to participate in at least one booster
course. An endline clinical assessment was conducted at
all 36 facilities with 70 MLP. A total of 687 (337 baseline
and 350 endline) patients were included in the analysis.
There were some incomplete data for the patient history,
physical examination, and laboratory tests as shown by
the sample sizes in Table 3. Details of the missing data
are in Additional files 3 and 4.
Baseline data
Arm A and B facilities were distributed relatively evenly
across geographic regions, with the exception that arm
A included disproportionately more facilities in the
southwest region and arm B included disproportionately
more facilities in the central region. Seventeen of the 36
facilities had previously participated in a national CQI
program for HIV care and 10 were previous or current
participants in a BIPAI on-site intervention; eight and
five, respectively in arm A, nine and five, respectively in
arm B.
The characteristics of the patient sample are described
in Table 2. The most common presenting complaints
were fever and cough, while the most frequent diagnoses
were uncomplicated malaria and cough (no pneumonia).
Three percent and 2 % of the patients were classified as
emergencies at baseline and endline, respectively, even
though clinical faculty were instructed not to use them
in the assessment of trainees.
Outcomes and estimation
Figure 2 shows the unadjusted average proportion of ap-
propriate tasks performed correctly comparing arms A
and B at baseline (time 0) and at endline (time 1). Base-
line clinical practice between arms A and B was compar-
able. Arm A had higher scores at endline than arm B
although these average proportions were not adjusted
for confounding variables.
Regression results for the full sample are shown in
Table 3. There was no statistically significant difference
in the practice of MLP in arm A compared to arm B at
baseline (time 0), but the percentage of appropriate la-
boratory tests ordered was lower (aRR = 0.85 (95 % CI =
0.72–1.01)) and the percentage of correct diagnoses was
higher (aRR 1.14 (95 % CI = 0.98-1.33)) in arm A than
arm B. For the primary model, the multivariate analysis
controls for differences across arms at baseline. Clinical
practice of MLP improved after IMID in arm B. Ad-
justed for covariates, there was a 12 % increase in the
proportion of appropriate history questions asked (aRR
= 1.12 (95 % CI = 1.04–1.21)) and a 40 % increase in the
proportion of physical systems examined correctly (aRR
= 1.40 (95 % CI = 1.16–1.68)). The aRRs within arm B
for laboratory tests, diagnosis, treatment, and patient/
caregiver education were close to one and not statisti-
cally significant.
The incremental effect of OSS was measured by the
ratio of the relative risks of outcomes at baseline to end-
line by trainees in arm A compared to the corresponding
relative risks in arm B. As shown in the last row of
Table 3, adjusted for covariates, OSS was associated
with an additional 18 % (aRRR = 1.18 (95 % CI = 1.06–
1.31)) improvement in patient history and 27 % (aRRR
= 1.27 (95 % CI = 1.02-1.59)) improvement in physical
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examination. The percentage of patients with appropri-
ate laboratory tests increased by 21 % (aRRR = 1.21
(95 % CI = 0.97–1.49)), but the effect was not statisti-
cally significant. Estimated effects for diagnosis, treat-
ment, and patient/caregiver education were smaller and
not statistically significant.
Sensitivity analyses
Two clinical faculty members at baseline who were not
able to participate in the endline assessment were re-
placed by two new members. Two additional clinical fac-
ulty present at baseline were only available to conduct
half of their endline assessments and were replaced with
two additional members for a total of four new clinical
faculty members at endline. Sensitivity analyses were
conducted using a balanced sample that consisted of as-
sessments by the eight clinical faculty who were present
both at baseline and at endline and who conducted
roughly the same number of assessments in each arm at
each time period.
The balanced sample comprised a total of 58 trainees
(29 in arm A and 29 in arm B) and 440 clinical assess-
ments (206 from arm A and 234 from arm B). There
were 215 and 225 clinical assessments at baseline and at
HF=Health facility; HC= Health center; MLP=Mid-level Practitioner; IMID=Integrated management of infectious diseases.
Baseline Clinical Assessment
HF (n=35), missing (n=1)
2 mid-level practitioner (MLP) trainees per facility
(n=69), missing n=3
Total clinical assessments conducted n=358





Health facilities randomized to arm A (n=18): 
35 HCIV and 1 hospital
2 MLP/facility (n=36): 24 clinical officers and 12 
registered nurses
Control arm
Health facilities randomized to arm B (n=18): 
32 HCIV and 4 hospitals
2 MLP /facility (n=36); 22 clinical officers, 10 
registered nurses and 4 registered midwives
Baseline clinical assessments (n=171)
Facilities (n=17)
MLP (n= 32)
Patients excluded from analysis: Age >14 (n=9), 
Missing age (n=1)
Assessments included in analysis (n=161)
Baseline clinical assessments (n=187)
Facilities (n=18)
MLP = (n=35)
Patients excluded from analysis: Age >14 (n=10), 
Missing age (n=1)
Assessments included in analysis (n=176)
Training courses
3-week core IMID Course (n=36)
Boost Course 1, 3 months after core course (n=36)
Boost Course 2, 6 months after core course (n=35)
MLP did not participate (n=1, due to illness)
On-site support for 9 months 
Participated in 7 of 9 2-day sessions beginning after 
the 3-week core IMID course (n=29)


















Health facilities (HF) assessed for eligibility n=38 (6 
hospitals and 32 Health Center (HC) IV)
Training courses
3-week core IMID Course (n=36)
Boost Course 1, 3 months after core course (n=34)
MLP did not participate (n=2), (1 due to 
illness, 1 due to job change)
Boost Course 2, 6 months after core course (n=34)
MLP did not participate (n=2, 1 due to illness, 
1 due to job change)
Endline clinical assessments (n=177)
Facilities (n=18)
MLP (n=35)
Did not participate due to illness (n=1)
All patients included in analysis
Endline clinical assessments (n=173)
Facilities (n=18)
MLP (n=35)
Did not participate due to illness (n=1)
All patients included in analysis
Fig. 1 Flow diagram of facilities and trainees
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endline respectively. As shown in Table 4, baseline
practice was comparable across arm A and arm B. Ad-
justed for covariates, IMID was not associated with
improvements. OSS was associated with an additional
31 % (aRRR = 1.31 (95 % CI = 1.13–1.53)) improvement
in patient history. The improvements in physical
Table 2 Descriptive characteristics of patients by time and arm
Baseline Endline
Arm A Arm B Total Arm A Arm B Total
N = 161 N = 176 N = 337 N = 177 N = 173 N = 350
Characteristic N (%) N (%) N (%) N (%) N (%) N (%)
Age
<5 130 (81) 153 (87) 283(84) 174 (98) 166 (96) 340 (97)
5-14 30 (19) 22 (13) 53 (16) 3 (2) 7 (4) 10 (3)
Triage Status
Emergency 3 (2) 6 (4) 9 (3) 1 (1) 4 (3) 3 (2)
Priorityb 22 (14) 3 (2) 25 (8)
Not emergency 150 (98) 157 (96) 307 (97) 132 (85) 152 (96) 284 (90)
Febrile or AT > 37.5 °C 82 (55) 89 (54) 171 (54) 65 (37) 49 (28) 114 (33)
Type of visit
New attendance 144 (94) 155 (95) 299 (94) 172 (99) 166 (97) 338 (98)
Re-attendance 10 (6) 9 (5) 19 (6) 2 (1) 6 (3) 8 (2)
Patient symptoms
Fever 131 (82) 154 (88) 285 (85) 151 (86) 143 (84) 294 (85)
HIV exposed 3 (2) 1 (1) 4 (1) 3 (2) 2 (1) 5 (1)
HIV-statusa 27 (20) 35 (22) 62 (21) 6 (4) 4 (3) 10 (3)
Cough 91 (57) 130 (74) 221 (66) 122 (69) 114 (67) 236 (68)
Diarrhea 48 (30) 52 (30) 100 (30) 44 (25) 48 (28) 92 (26)
Vomiting 29 (18) 32 (18) 61 (18) 24 (14) 36 (21) 60 (17)
Ear pain 11 (7) 6 (4) 17 (5) 11 (7) 6 (4) 17 (5)
Ear discharge 9 (6) 4 (2) 13 (4) 8 (5) 3 (2) 11 (3)
Diagnoses
One or more danger signs 0 (0) 2 (1) 2 (1) 3 (2) 2 (1) 5 (1)
Anemia 10 (6) 19 (11) 29 (9) 20 (11) 22 (13) 42 (12)
Cough (no pneumonia) 58 (36) 65 (37) 123 (36) 72 (41) 66 (38) 138 (39)
Pneumonia 29 (18) 37 (21) 66 (20) 33 (19) 23 (13) 55 (16)
Diarrhea – acute 24 (15) 30 (17) 54 (16) 19 (11) 26 (15) 42 (13)
Ear infection 12 (7) 4 (2) 16 (5) 9 (5) 8 (5) 17 (5)
Malaria (uncomplicated) 74 (46) 83 (49) 160 (47) 61 (34) 62 (36) 123 (35)
Malaria (complicated) 21 (13) 33 (19) 54 (16) 15 (8) 19 (11) 34 (10)
Malnutrition (LWA) 10 (6) 25 (14) 35 (10) 18 (10) 9 (5) 27 (8)
Severe malnutrition 3 (2) 1 (1) 4 (1) 4 (2) 3 (2) 7 (2)
UTI 6 (4) 10 (6) 16 (5) 3 (2) 8 (5) 11 (3)
Number of diagnoses
1 62 (39) 54 (31) 116 (35) 72 (41) 72 (41) 147 (42)
2 64 (40) 62 (35) 126 (38) 69 (39) 66 (38) 135 (39)
>2 33 (21) 60 (34) 93 (28) 36 (20) 32 (19) 68 (19)
a At baseline, reflects children and mothers (of children less than 5 years) whose HIV status was known regardless of results while at endline, it reflects those who
were HIV positive. For trainee assessment, of interest was whether the trainee made an effort to ask or not. AT = axillary temperature, LWA = low weight for age
b Not included on the baseline assessment tool
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examination (aRRR = 1.27 (95 % CI = 0.99–1.63)) and
laboratory tests (aRRR = 1.24 (95 % CI = 0.99–1.54))
were large, but not statistically significant.
Given there were no statistically significant differences in
clinical practice across arms at baseline, we conducted an
analysis using only the endline sample, comparing arm A
to arm B to take advantage of additional variables that were
available only at endline. Using the full sample at endline,
OSS was associated with improved clinical practice across
all sets of tasks assessed, but improvement was not statisti-
cally significant for laboratory tests and diagnoses (See
Table 5). In addition to improvement in patient history
(aRR = 1.24 (95 % CI = 1.14–1.35)) and physical examin-
ation (aRR = 1.26 (95 % CI = 1.12–1.41)), there were effects
of OSS on prescribing of appropriate treatment (aRR = 1.08
(95 % CI = 1.01–1.16)) and patient/caregiver education
(aRR = 1.13 (95 % CI = 1.02–1.25)).
Sensitivity analyses were conducted with imputation of
missing data on the clinical tasks. In estimates of the full
sample, the direction and significance of the results for
the full sample did not change with either assumption
(missing equal to zero or missing equal to one). The one
exception was for laboratory tests, where the incremen-
tal effect of OSS was statistically significant, when miss-
ing data on the task was assumed to mean that it wasn’t
performed (aRRR = 1.27, (95 % CI = 1.00–1.60)).
Discussion
The trial demonstrated an incremental effect of OSS at
improving patient history and physical examination, but
Table 3 Primary analysis: Adjusted relative risks (95 % confidence intervals) for performing tasks correctly for the full sample across
arms and time periods
Sets of clinical tasks
Effects Patient history Physical
examination
Laboratory tests Diagnosis Treatment Patient/
caregiver
education
Sample Size N = 573 N = 639 N = 621 N = 674 N = 683 N = 667
Arm A vs. Arm B at time 0 1.02 (0.93-1.11) 0.97 (0.80-1.18) 0.85 (0.72-1.01) 1.14 (0.98-1.33) 1.00 (0.92-1.09) 1.07 (0.95-1.19)
Time 1 vs. time 0 in Arm B
(IMID)
1.12 (1.04-1.21) 1.40 (1.16-1.68) 0.95 (0.82-1.09) 1.05 (0.91-1.21) 1.01 (0.93-1.10) 1.03 (0.92-1.16)
Change Arm A vs. Arm B (IMID
and OSS), RRR
1.18 (1.06-1.31) 1.27 (1.02-1.59) 1.21 (0.97-1.49) 0.92 (0.77-1.10) 1.07 (0.96-1.19) 1.07 (0.94-1.23)
Estimates were adjusted for: sequence of clinical assessment, cadre of trainee, complexity of patient determined by number of diagnoses and age of patient less
than one year, whether the health facility received support from the Health Care Improvement project or not, whether the facility received the on-site intervention
from Baylor International Pediatric AIDS Initiative or not, and the clinical faculty determined by cadre of faculty and whether s/he attended relevant assessment
training session or not
























Sets of clinical tasks
Time 0, Arm A
Time 0, Arm B
Time 1, Arm A
Time 1, Arm B
Fig. 2 Unadjusted average proportion of appropriate tasks performed correctly by arm and time period
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not laboratory tests, diagnosis, treatment, or patients/
caregiver education. These results for patient history
were robust in sensitivity analyses with a balanced sam-
ple. Results for both patient history and physical exam-
ination were robust in an endline only comparison, and
under alternative assumptions about missing values.
There was also evidence that the IMID training program
improved patient history and physical examination, but
by the nature of the study design, we were unable to ad-
just for other changes that occurred at the facilities
across time periods such as improved infrastructure,
diagnostic capability etc. The effects of IMID were
smaller and not statistically significant in the balanced
sample. During OSS, a MLP was mentored one-on-one
and what they previously learned in IMID was translated
into their work environment. Regular reminders and ap-
plying principles to different patients resulted in better
clinical practice.
Our results that IMID and OSS improved patient
history and physical examination are consistent with
the results from the IMCI Multi-Country Evaluation
[14–16, 40]. We did not find strong evidence that
IMID and OSS improved laboratory tests, diagnosis,
treatment, and patient/caregiver education, whereas
several evaluations of IMCI have shown effects on
treatment and patient/caregiver education [15, 16, 40]
[19]. There are three potential explanations for the ab-
sence of effects on these sets of tasks: 1) the interven-
tion was not effective, 2) trainee practice on these
tasks was higher at baseline than on patient history
and physical examination, and had less room for im-
provement, and 3) the full effects were not measured
because of the structure of the clinical assessment.
Concerning the third explanation, the IDCAP clinical
assessment was structured with an interruption after
the patient history and physical examination when the
clinical faculty completed or corrected them. From this
point forward, the trainee had the results of a complete
patient history and physical examination and may have
been able to prescribe correct treatment and provide
appropriate information to patients and caregivers.
The intervention may have had larger and significant
effects on these tasks if the clinical faculty did not
intervene to complete the patient history and physical
examination.
Horwood et al., in South Africa [41] conducted focus
group discussions to establish whether skills gained after
IMCI training were sufficient or whether additional fol-
low up visits were required to maintain adequate skills.
Findings from this South African study suggested that
IMCI training course was an effective way to learn skills
but follow-up was needed to improve implementation
Table 4 Sensitivity analysis: Adjusted relative risks (95 % confidence intervals) of performing task correctly for the balanced sample*
across arms and time periods
Sets of clinical tasks







Sample Size N = 344 N = 404 N = 397 N = 435 N = 438 N = 425
Arm A vs. Arm B at time 0 0.96 (0.86-1.08) 1.05 (0.87-1.26) 0.87 (0.74-1.02) 1.06 (0.90-1.24) 1.05 (0.97-1.15) 1.04 (0.92-1.18)
Time 1 vs. time 0 in Arm B (IMID) 1.00 (0.92-1.10) 1.15 (0.93-1.43) 0.86 (0.74-1.01) 0.86 (0.73-1.00) 0.96 (0.87-1.06) 1.03 (0.91-1.17)
Change Arm A vs. Arm B (IMID and OSS),
RRR
1.31 (1.13-1.53) 1.27 (0.99-1.63) 1.24 (0.99-1.54) 1.17 (0.96-1.44) 1.08 (0.96-1.21) 1.06 (0.91-1.24)
*Balanced consists of observations for whom the clinical faculty at baseline and endline were the same, with a fixed effect for the observer
Estimates were adjusted for: sequence of clinical assessment, cadre of trainee, complexity of patient determined by number of diagnoses and age of patient less
than one year, whether the health facility received support from the Health Care Improvement project or not, whether the facility received on-site intervention
from Baylor International Pediatric AIDS Initiative or not
RRR = Ratio of relative risks comparing change in practice at time 1 to practice at time 0 across arms
Table 5 Sensitivity analysis: Adjusted relative risks (95 % confidence intervals) of performing task correctly for the endline sample
across arms
Sets of clinical tasks
Effects Patient history Physical examination Laboratory tests Diagnosis Treatment Patient/caregiver education
Sample Size N = 312 N = 350 N = 323 N = 345 N = 350 N = 346
Arm A vs Arm B at time 1 1.24 (1.14-1.35) 1.26 (1.12-1.41) 1.02 (0.91-1.15) 1.10 (0.95-1.28) 1.08 (1.01-1.16) 1.13 (1.02-1.25)
Two additional patient history tasks were asking for presence of danger signs and measles status. Two additional physical systems examined were mouth and
growth assessment
Estimates were adjusted for: sequence of clinical assessment, cadre of trainee, complexity of patient determined by number of diagnoses and age of patient less
than one year, whether the health facility received support from the Health Care Improvement project or not, whether the facility received on-site intervention
from Baylor International Pediatric AIDS Initiative or not, and the clinical faculty determined by cadre of faculty and whether s/he attended relevant assessment
training session or not
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and retention of the skills. Facility based training as im-
plemented in IMCI evaluations provided an opportunity
to mentor health workers and is good value for money
[40, 42].
Two strengths of the IDCAP clinical assessments were
the relatively large number of observations per trainee,
and the accurate patient information recorded by the
clinical faculty member. Each trainee was observed an
average of five times in each time period. The IDCAP
clinical assessment was designed to observe the broad
variety of children who present in a primary care facility.
The patient history section was designed with follow-up
questions as well as key questions, and the analysis ac-
commodated differences in the number of appropriate
questions across patients. The interruption after the pa-
tient history and physical examination ensured that
emergency and complex cases benefited from the expert-
ise of the clinical faculty, albeit having drawbacks as
noted above.
Limitations of this study
Firstly, two of the clinical faculty members at baseline did
not conduct endline assessments and four new clinical fac-
ulty members conducted only endline assessments. To ad-
dress this instability in measurement, we also analyzed the
samples for whom the clinical faculty members were
present both at baseline and endline and balanced across
arms. The balanced sample however, no longer represented
the full, randomized sample. Secondly, the missing informa-
tion at baseline, especially for patient history and physical
examination, could have an impact on the results. For the
pre/post analysis, we may not be able to distinguish the ef-
fects of IMID in arm B from the more complete sample of
patients in time 1. The sensitivity analyses however, showed
that the results for patient history and physical examination
were robust under two alternate assumptions about the
missing values. The missing data analysis demonstrated the
range of results with extreme values for the tasks that were
used to construct each dependent variable. Multiple imput-
ation of missing values would have been challenging, be-
cause the number of appropriate tasks varied across
patients for four of the dependent variables. Thirdly, given
that a 5 % level of significance was used despite multiple
comparisons, it is possible that we erroneously concluded
that the effects of the interventions were statistically signifi-
cant. Fourthly, MLP were observed managing a conveni-
ence sample of patients rather than a random sample. It
would be difficult to select patients at random in the ab-
sence of an appointment system. It’s unclear however,
what how the selection process may have biased the re-
sults. Fifthly, trainees and observers did not know the
allocation of facilities to arm during most of the base-
line data collection, but they knew during the interven-
tion and endline data collection. The clinical faculty
did not observe their mentees at endline, but it’s pos-
sible that the observers were biased in favor of inter-
vention arm. Finally, the clinical assessment data were
limited to two time points at each facility, and don’t
provide details of the monthly progress in clinical prac-
tice. To the extent that there were temporal trends in
clinical practice, arm B controlled for them, so that the
effect of OSS is measured accurately. The pre/post
change in arm B however, could reflect these trends as
well as the effects of IMID.
Implications
Our results underscore the importance of continued on-
site support or mentorship in addition to continuous
medical education as a means to improve health worker
practice. Task-shifting is a potentially cost-effective ap-
proach to addressing the human resource shortages in
resource-limited settings. Programs that have embraced
this approach should consider incorporating mentorship
activities to improve the clinical practice of health
workers and scaling up of health care services.
Conclusions
On-site training and continuous quality improvement
activities were associated with incremental improve-
ments in patient history and physical examination
among the MLP. This approach to capacity development
may be more beneficial for developing countries espe-
cially as we move towards task shifting beyond HIV and
AIDS care to management of common childhood infec-
tions. Companion articles will address the effects on
clinical practice of HIV care, mortality among children
less than five years of age and cost-effectiveness.
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